Drugs / VBY-036
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01892891 | Jul → Nov 2013 | — | Virobay Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01911637 | May → Jul 2013 | — | Virobay Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VBY-036 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01892891 ↗ |
| Action | Inhibit | “Cathepsin S inhibitor” NCT01892891 ↗ |
| Route | Oral | “Oral Doses of VBY-036” NCT01892891 ↗ |